Sarah Whelan, PhD
Science Writer
Sarah joined Technology Networks in 2022 after completing a PhD in cancer biology, where her research focused on the development of colon cancers. In her role as science writer and editor, Sarah covers scientific news and a range of other content types, leading the site's coverage of drug discovery, biopharma and cancer research content.
Latest Content
News
B12 Deficiency and Multiple Sclerosis Share Intriguing Similarities
A novel molecular link between vitamin B12 and MS in astrocytes – important non-neuronal brain cells – has been unearthed in a new study. The research suggests that brain-targeted B12 formulations may support MS treatment.
News
Drug Shows Promise in Kidney Disease Trial
In a Phase 2 trial of patients with chronic kidney disease, an experimental drug reduced albuminuria – albumin in the urine, a sign of kidney damage.
News
PFAS Exposure Linked to Worse Bone Health in Young People
Exposure to per- and polyfluoroalkyl substances (PFAS) can lead to lower bone density in adolescents and young adults – particularly for those of Hispanic origin, according to a new longitudinal study.
News
139 Genes Set Human Cognitive Ability Apart From Other Primates
A group of 139 genes commonly expressed in primate brains – which underwent evolutionary divergence only in human brains – may be the source of our unique cognitive abilities according to a study led by the University of Toronto.
News
Arthritis Drug May Offer Hope for Type 1 Diabetes
A common drug used for rheumatoid arthritis – baricitinib – has shown promising results for patients with type 1 diabetes in a world-first trial, showing it could limit the progression of the disease within the first 100 days of diagnosis.
News
Human Cell “Biobots” Encourage Neuron Regrowth in Lab Dishes
Made from human cells, researchers have created tiny biological robots – called Anthrobots – that can move across surfaces and even encourage regrowth in damaged regions in dishes of lab-grown neurons.
News
Lidocaine May Activate Bitter Taste Receptors To Kill Cancer Cells
The common numbing agent lidocaine can activate bitter taste receptors leading to cancer cell death, according to a new study, which could lead to clinical trials of lidocaine alongside standard treatments for head and neck cancers.
News
Higher Cognitive Ability Linked to Voting Against Brexit, Study Finds
People with higher cognitive ability may have been more likely to vote to “Remain” during the Brexit referendum – a vote that decided whether the United Kingdom should leave or remain a member of the European Union – according to a new study.
News
Nutrient in Beef and Dairy May Improve Immune Cell Responses to Cancer
A fatty acid found in meat and dairy has been found to increase cancer-fighting T-cell activity according to a new study, suggesting trans-vaccenic acid has the potential to be used as a nutritional supplement to complement cancer therapies.
News
Are Climate Change Concerns Affecting People’s Reproductive Choices?
Complex ethical, environmental and political concerns surrounding climate change may be causing people to reconsider having children, according to research from University College London.
Advertisement
